Hosted on MSN
The massive flywheels keeping the power grid stable
On April 28, 2025, a massive blackout plunged Spain into darkness, disrupting transportation, communications, emergency services, and daily life across the country. The outage quickly spread beyond ...
An eight-month-old infant with rare but severe epilepsy has received an experimental gene replacement in a historic medical moment. The child was one of the first in the world to be treated with gene ...
The $225m investment will be handed down this month in a state budget widely predicted to hold few sweeteners as Treasurer Daniel Mookhey spreads a message of fiscal restraint in a high inflationary ...
NEW YORK - OCTOBER 17: Scott Pelley, Correspondent, 60 MINUTES. (Photo by Michele Crowe/CBS News via Getty Images) “She’s murdering 60 Minutes,” Pelley said, according to sources with knowledge of the ...
Mayim Bialik is speaking out candidly about a severe reaction she says she experienced after taking a GLP-1 medication, revealing that a single low-dose injection led to weeks of debilitating ...
We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors ...
In a breakthrough for longevity science, a reverse-aging treatment has been injected into a human. The technique is a sought-after solution for improving longevity by reprogramming cells. Competitors ...
OpenAI announced a new feature that it says will provide additional protection from prompt injection attacks, where malicious chatbot instructions are hidden in web pages and other content sources.
When I started working on a book about Nvidia in early May 2023, the artificial-intelligence boom was still in its infancy. Based on my years covering the chip sector, and tech more broadly, I was ...
The world's first anti-ageing gene therapy has just been injected into a human - here's what it does
First human gets experimental gene shot to rewind ageing cells in the eye Life Biosciences has dosed its first patient with ER-100, a treatment that uses partial cellular reprogramming to target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results